I. Bartošek
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 11
- Biochemistry top 10%
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 9
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 11
-
- Effects and risks of endocrine disrupting chemicals 6
-
- Liver Disease Diagnosis and Treatment 6
-
- Diet and metabolism studies 4
-
- Cancer therapeutics and mechanisms 4
-
- Electron Spin Resonance Studies 4
In The Last Decade
I. Bartošek
59 papers receiving 845 citations
Peers
Comparison fields: 5 of 99
- Pharmacology 163
- Biochemistry 70
- Clinical Biochemistry 65
- Oncology 238
- Hepatology 51
Countries citing papers authored by I. Bartošek
This map shows the geographic impact of I. Bartošek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Bartošek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Bartošek more than expected).
Fields of papers citing papers by I. Bartošek
This network shows the impact of papers produced by I. Bartošek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Bartošek. The network helps show where I. Bartošek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I. Bartošek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 7 | |
| 2 | 1991 | 13 | |
| 3 | 1991 | 1 | |
| 4 | 1990 | 13 | |
| 5 | 1989 | 21 | |
| 6 | Antitumor activity of the novel nitrosourea S10036 in rodent tumors. | 1989 | 17 |
| 7 | 1988 | 2 | |
| 8 | Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats. | 1988 | 4 |
| 9 | 1986 | 4 | |
| 10 | 1986 | 3 | |
| 11 | An experimental rat model of local bone cancer invasion and its responsiveness to ethane-1-hydroxy-1,1-bis(phosphonate). | 1985 | 24 |
| 12 | 1985 | 16 | |
| 13 | 1983 | 10 | |
| 14 | 1983 | 2 | |
| 15 | 1983 | 16 | |
| 16 | 1978 | 7 | |
| 17 | 1978 | 9 | |
| 18 | Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect. | 1976 | 14 |
| 19 | 1974 | 8 | |
| 20 | 1967 | 1 |
About I. Bartošek
I. Bartošek is a scholar working on Pharmacology, Clinical Biochemistry, Biophysics, Biochemistry and Oncology, having authored 60 papers that have together received 896 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (11 papers), Metabolism and Genetic Disorders (9 papers), Effects and risks of endocrine disrupting chemicals (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Diet and metabolism studies (4 papers), Cancer therapeutics and mechanisms (4 papers) and Electron Spin Resonance Studies (4 papers). The work is most often cited by research in Pharmacology (163 citations), Biochemistry (70 citations), Clinical Biochemistry (65 citations), Oncology (238 citations) and Hepatology (51 citations). I. Bartošek has collaborated with scholars based in Italy, France and Germany. Frequent co-authors include A. Guaitani, Leon L. Miller, Silvio Garattini, Pia Villa, Renato Urso, M. Gerna, Emma Riva, Paolo Neyroz, Monica Corada and M.G. Donelli. Their work appears in journals such as Biochemical Pharmacology, Toxicology Letters, Xenobiotica, Oncology and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.